Articles On Vectus Biosystems (ASX:VBS)

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

Benchmark down 1.6%, small caps 2% Shares dive on surprise size of rate hike  Dateline Resources lifts on 100m intercept   In some miserable pre-rate day trade the small caps index and the ASX200 were down 1.5% and 1% respectively as trad...

Vectus announced promising Phase 1 study results Emyria’s CBD capsule demonstrates  bioavailability and dose safety profile Bod Australia also reports promising results on its cannabis extract study   Vectus up 13% on Phase 1 results Fibr...

The S&P/ASX 200 Health Care Index (ASX: XHJ) is in the red today, but one ASX biotech share is beating the trend. The Vectus Biosystems Ltd (ASX: VBS) share price is soaring 13.6%, currently trading at $1.25. In contrast, the ASX 200...

Peter Switzer talks with Vectus Biosystems (VBS) CEO, Maurie Stang.

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

It’s been an emotional ride for fans of the ASX200 (XJO) which, alongside the Emerging Companies (XEC) index, (down 0.6%) gave up its early gains in a topsy-turvy Monday session. Just after the close, the XJO was weepingly flat – well, up 0...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Trading Places is Stockhead’s semi-regular, pretty damn fascinating recap of the latest red flag buying and selling of ASX small cap shares.  It is here that the rubber really hits the road for fund managers, stakeholders, distant (and not-...

At the time of writing, the ASX 200 Health Index (XHJ) is down by 1.90%, while the benchmark ASX 200 has fallen by 0.3%. Genomics specialist Genetic Technologies (ASX:GTG) says that its laboratory in Fitzroy, Melbourne has received simultan...

Wall Street down ahead of long weekend Queen Elizabeth has reportedly tested positive for COVID-19, but doctors say she is in good spirits with only minor symptoms. To the markets, and the standoff between Russia and Ukraine continues to ca...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

The life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, the share prices of major vaccine-producing companies have surged astronomically as COVID-19  ravaged the world. Nasdaq-listed BioNTech, which...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Just like yesterday the ASX rallied for most of the day but retreated in the afternoon and today closed in the red. The ASX 200 was down 0.08% at 7,375 points. Another difference from yesterday was tech was the best sector gaining 1.7% whil...

After treading water since the start of September, the ASX 200 took a dive in Thursday trade to finish 1.90% lower. Stocks lost ground at the opening bell and kept falling throughout the day, with steady falls across the board. Local stocks...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

IDT Australia (ASX:IDT) jumped more than 20% after announcing that it has formalised activities with the Australian Government to potentially assist with the production of a COVID-19 vaccine. There was recent media interest surrounding a mR...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading day. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intrad...

Fertoz Ltd (ASX:FTZ) topped the pops with a red hot 14-day RSI of 93 after two massive days to finish the week. A total of 18 ASX companies posted a 14-day RSI above 70 last week, down from 25 in the week prior. Each week, Stockhead recaps...

Summary The S&P/ASX200 closes Thursday session a tad bit lower, dropped 0.37%. eCargo posts gains on partnership with NZ's Fonterra unit Seven West Media shares rises on strong FY21 forecast The S&P/ASX200 closed lower Thu...

Summary The ASX 200 ends 27.20 points or 0.37% lower at 7,359. Seven out of 11 sectors ended in red, while telecom and energy emerging as the worst performer. The market sentiment was dented as US Federal Reserve indicated a rate hike...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading day. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intrad...

Wall Street down as Fed signals two rates rises by 2023 All major indices in the US fell on Thursday, after an announcement by the central bank that surprised the market. The Dow Jones fell by 0.77%, S&P 500 by 0.54%, and tech heavy Nas...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

A quick wrap of the ASX’s key winners and losers on Thursday, August 27. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 760 stocks rose, 634 declined and...

A quick wrap of the key winners and losers on Wednesday, May 20. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potential market-moving announcements during the day. WINNERS: CODE COMPANY PRICE...

Now may not be the time to tell investors you’re about to start selling cosmetics to China, but ASX disclosure rules mean Roolife (ASX:RLG) has to unleash their news about a $1.3m revenue contract on the market today. The company has done a...

On Stockhead today, the major oilies want to help Australia build a big hydrogen industry, the private eSports company that wants to disrupt the industry and Osteopore is on track to win the title of 2019’s best performing IPO. But first:  ...